MAPS News company blog

FDA grants Breakthrough Therapy designation to MDMA for treatment of PTSD

The non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to MDMA for the treatment of posttraumatic stress disorder (PTSD). MAPS and the FDA have also reached agreement under the Special…
Points
428
HN comments
113
Submissions
1
Cited by
3 commenters

Society, Policy & CultureScience & Space2017

On Hacker News

SubmittedTitle on HNPointsComments
Aug 28, 2017FDA grants Breakthrough Therapy designation to MDMA for treatment of PTSD by anythingnonidin428113

Cited in comments

Linked from 3 Hacker News comments by 3 different people, from Aug 2017 to Oct 2017.

Most recent:

Search every comment that links here →

More from MAPS News

All 5 posts →

Related posts from the same era